We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure coreplatform@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This study was designed to investigate the effects of dietary starch structure on muscle protein synthesis and gastrointestinal amino acid (AA) transport and metabolism of goats. Twenty-seven Xiangdong black female goats (average body weight = 9·00 ± 1·12 kg) were randomly assigned to three treatments, i.e., fed a T1 (normal maize 100 %, high amylose maize 0 %), T2 (normal maize 50 %, high amylose maize 50 %) and T3 (normal maize 0 %, high amylose maize 100 %) diet for 35 d. All AA in the ileal mucosa were decreased linearly as amylose:amylopectin increased in diets (P < 0·05). The plasma valine (linear, P = 0·03), leucine (linear, P = 0·04) and total AA content (linear, P = 0·03) increased linearly with the increase in the ratio of amylose in the diet. The relative mRNA levels of solute carrier family 38 member 1 (linear, P = 0·01), solute carrier family 3 member 2 (linear, P = 0·02) and solute carrier family 38 member 9 (linear, P = 0·02) in the ileum increased linearly with the increase in the ratio of amylose in the diet. With the increase in the ratio of amylose:amylopectin in the diet, the mRNA levels of acetyl-CoA dehydrogenase B (linear, P = 0·04), branched-chain amino acid transferase 1 (linear, P = 0·02) and branched-chain α-keto acid dehydrogenase complex B (linear, P = 0·01) in the ileum decreased linearly. Our results revealed that the protein abundances of phosphorylated mammalian target of rapamycin (p-mTOR) (P < 0·001), phosphorylated 4E-binding protein 1 (P < 0·001) and phosphorylated ribosomal protein S6 kinases 1 (P < 0·001) of T2 and T3 were significantly higher than that of T1. In general, a diet with a high amylose ratio could reduce the consumption of AA in the intestine, allowing more AA to enter the blood to maintain higher muscle protein synthesis through the mTOR pathway.
Inflammation might play a role in bipolar disorder (BD), but it remains unclear the relationship between inflammation and brain structural and functional abnormalities in patients with BD. In this study, we focused on the alterations of functional connectivity (FC), peripheral pro-inflammatory cytokines and their correlations to investigate the role of inflammation in FC in BD depression.
Methods
In this study, 42 unmedicated patients with BD II depression and 62 healthy controls (HCs) were enrolled. Resting-state-functional magnetic resonance imaging was performed in all participants and independent component analysis was used. Serum levels of Interleukin-6 (IL-6) and Interleukin-8 (IL-8) were measured in all participants. Correlation between FC values and IL-6 and IL-8 levels in BD was calculated.
Results
Compared with the HCs, BD II patients showed decreased FC in the left orbitofrontal cortex (OFC) implicating the limbic network and the right precentral gyrus implicating the somatomotor network. BD II showed increased IL-6 (p = 0.039), IL-8 (p = 0.002) levels. Moreover, abnormal FC in the right precentral gyrus were inversely correlated with the IL-8 (r = −0.458, p = 0.004) levels in BD II. No significant correlation was found between FC in the left OFC and cytokines levels.
Conclusions
Our findings that serum IL-8 levels are associated with impaired FC in the right precentral gyrus in BD II patients suggest that inflammation might play a crucial role in brain functional abnormalities in BD.
To evaluate the effects of dietary Ca intake and Ca supplementation during pregnancy on low birth weight (LBW) and small for gestational age (SGA) infants.
Design:
A birth cohort study was conducted in 2010–2012 at the Gansu Provincial Maternity and Child Care Hospital in Lanzhou, China.
Setting:
A birth cohort study.
Participants:
Totally, 9595 pregnant women who came to the hospital for delivery at 20 weeks of gestation or more, and who were 18 years of age or older.
Results:
Compared with non-users, Ca supplement users had a reduced risk of LBW infants (OR = 0·77, 95 % CI: 0·63, 0·95) and a reduced risk of nulliparous women giving birth to LBW infants (OR = 0·75, 95 % CI: 0·58, 0·98) (P < 0·05). More specifically, both the use of Ca supplement before conception and during pregnancy (OR = 0·44, 95 % CI: 0·19, 0·99) and during pregnancy only (OR = 0·80, 95 % CI: 0·65, 0·99) had the main effect of reducing risk of nulliparous women giving birth to LBW infants (P < 0·05). There was no association between Ca supplementation and SGA (OR = 0·87, 95 % CI: 0·75, 1·01) (P > 0·05). However, higher dietary Ca intake during pregnancy decreases the risk of both LBW (quartile 2: OR = 0·72, 95 % CI: 0·55, 0·94; quartile 3: OR = 0·68, 95 % CI: 0·50, 0·62) and SGA infants (quartile 2: OR = 0·77, 95 % CI: 0·63, 0·95; quartile 3: OR = 0·71, 95 % CI: 0·57, 0·88, quartile 4: OR = 0·71, 95 % CI: 0·57, 0·88) (P < 0·05).
Conclusions:
Ca supplementation and adequate dietary intake of Ca during pregnancy are associated with a decreased risk of LBW infants born to nulliparous women.
Understanding the patterns of treatment response is critical for the treatment of patients with schizophrenia; one way to achieve this is through using a longitudinal dynamic process study design.
Aims
This study aims to explore the response trajectory of antipsychotics and compare the treatment responses of seven different antipsychotics over 6 weeks in patients with schizoprenia (trial registration: Chinese Clinical Trials Registry Identifier: ChiCTR-TRC-10000934).
Method
Data were collected from a multicentre, randomised open-label clinical trial. Patients were evaluated with the Positive and Negative Syndrome Scale (PANSS) at baseline and follow-up at weeks 2, 4 and 6. Trajectory groups were classified by the method of k-means cluster modelling for longitudinal data. Trajectory analyses were also employed for the seven antipsychotic groups.
Results
The early treatment response trajectories were classified into a high-trajectory group of better responders and a low-trajectory group of worse responders. The results of trajectory analysis showed differences compared with the classification method characterised by a 50% reduction in PANSS scores at week 6. A total of 349 patients were inconsistently grouped by the two methods, with a significant difference in the composition ratio of treatment response groups using these two methods (χ2 = 43.37, P < 0.001). There was no differential contribution of high- and low trajectories to different drugs (χ2 = 12.52, P = 0.051); olanzapine and risperidone, which had a larger proportion in the >50% reduction at week 6, performed better than aripiprazole, quetiapine, ziprasidone and perphenazine.
Conclusions
The trajectory analysis of treatment response to schizophrenia revealed two distinct trajectories. Comparing the treatment responses to different antipsychotics through longitudinal analysis may offer a new perspective for evaluating antipsychotics.
A series of double-perovskite LaAMnNiO6 (A = La, Pr, Sm) catalysts with mesoporous morphology was prepared by a sol–gel method and further applied into photothermal synergistic degradation of gaseous toluene. Transmission electron microscopy and Brunauer–Emmett–Teller characterizations confirmed that double-perovskite LaAMnNiO6 (A = La, Pr, Sm) had obvious mesoporous structure, which can provide a larger specific surface area and further enhancing the reactivity of catalyst. UV-vis and X-ray photoelectron spectroscopy characterization illustrated that LaSmMnNiO6 possessed higher adsorption oxygen content and light absorption capacity, which contribute to the occurrence of catalytic oxidation in the Mars–van Krevelen redox cycle mechanism. A group of active tests showed that the double-perovskite LaSmMnNiO6 catalyst had a lower reaction initiation temperature (starting reaction at 75 °C) and a lower activity temperature of optimal reaction (more than 90% at 255 °C). Moreover, the research on reaction kinetics of the catalyst demonstrated that LaAMnNiO6 (A = La, Pr, Sm) had lower activation energy and thus exhibited better catalytic activity. The results of the study indicate that the double-perovskite LaAMnNiO6 (A = La, Pr, Sm) has broad application prospects in the field of volatile organic pollutant degradation.
Underground Nuclear Astrophysics in China (JUNA) will take the advantage of the ultra-low background in Jinping underground lab. High current accelerator with an ECR source and detectors were commissioned. JUNA plans to study directly a number of nuclear reactions important to hydrostatic stellar evolution at their relevant stellar energies. At the first period, JUNA aims at the direct measurements of 25Mg(p,γ)26 Al, 19F(p,α) 16 O, 13C(α, n) 16O and 12C(α,γ) 16O near the Gamow window. The current progress of JUNA will be given.
A series of metal oxides (MnFeOx, MnCrOx, MnTiOx, and MnFeTiOx) supported on attapulgite (ATP) were synthesized by coprecipitation for the low-temperature selective catalytic reduction (SCR) of NOx with NH3. Then, they were subjected to appropriate characterizations for their properties (XRD, TEM, BET, XPS, etc.). The catalytic activity of MnFeTiOx/ATP catalyst was over 95% NOx conversion within a wide temperature window between of 175 and 300 °C, and 88% N2 selectivity. Moreover, MnFeTiOx/ATP presented excellent potassium resistance relative to the traditional V–W–Ti catalyst, and its denitration performance was significantly improved. The NOx conversion rate could be restored to nearly 90% at 210 °C after removing potassium via washing of K–MnFeTiOx/ATP. In addition, the MnFeTiOx/ATP showed better SO2 resistance and stability than the traditional V–W–Ti catalyst. Therefore, the MnFeTiOx/ATP catalyst has been proved to have broad prospects in NH3-SCR.
In the new generation of Global Navigation Satellite Systems (GNSS), dual-frequency constant envelope multiplexing is widely desired and is becoming an important subject in signal design. Considerable work has been devoted to multiplexing for the Alternative Binary Offset Carrier (AltBOC)-like signal model, for which each sideband consists of two or fewer signal components. In this paper, a phase-aligned dual-frequency constant envelope multiplexing technique is proposed for a general dual-frequency signal model. This multiplexing technique can be used to combine two constant-envelope-modulated signals in two sidebands into a composite signal with a constant envelope, where the constant-envelope-modulated signal in each sideband consists of an arbitrary number of signal components with an arbitrary power ratio and phase relationship among the signal components. A Lookup Table (LUT)-based signal generation method is also proposed, for which the required driving clock rate of the signal generator can be flexibly adjusted to meet the requirements of the satellite payload. Applications for the AltBOC-like signal model and a general dual-frequency signal model in the Beidou B1 band validate the flexibility and high multiplexing efficiency of our method. Specifically, AltBOC is a special case of the proposed method.